EurekAlert! -
23 Feb 2015 07:00
(Spanish National Research Council (CSIC)) Researchers at the Spanish National Research Council have found that the Bazedoxifene acetate, used to treat osteoporosis, is useful to treat a rare disease, the hereditary hemorrhagic telangiectasia.
Share this Article